Rebamipide New

Data Sheet For research use only. Not for human use.

Cat. No. ：BCP07230CAS No. ：90098-04-7Purity：98%

Get Quotation Now

Tel: 0086-17754423994 or orders@biochempartner.com

* Required Fields.

Please complete the form below and you will get the price list in 1 minute.

* Required Fields.

Please complete the form below and we will contact you shortly.

* Required Fields.

Please complete the form below and we will contact you shortly.

CAS No.	90098-04-7	Cat. No.	BCP07230
Name	Rebamipide
Synonyms	Mucosta;OPC12759;Proamipide;Rebagen;OPC 12759;OPC-12759;
SMILES
Chemical Name
Formula	C19H15ClN2O4	M. Wt	370.79
Purity	98%	Storage	Store at 4-8°C
Description	Rebamipide is the first anti-gastric ulcer and antigastritis drug that not only increases endogenous prostaglandin in gastric mucosa but also scavenges oxygen-derived free radicals and inhibits their production. The inhibitory effect of rebamipide on lipid peroxidation induced by a free radical initiator was also demonstrated by the in vitro system using rat gastric mucosal homogenates. These data indicate that rebamipide offers a potential for protection against reactive oxygen- and activated neutrophil-associated gastric mucosal injury by scavenging hydroxyl radical and inhibiting neutrophil activation or lipid peroxidation. Rebamipide can contribute to the management of patients who are taking NSAIDs or are infected with H. pylori. Rebamipide may enhance eradication of H. pylori-infection using standard eradication therapy . Rebamipide is beneficial for obtaining a better quality of ulcer healing and reduction of future ulcer relapse.